Cargando…

Knowledge and attitude assessment of Iranian multiple sclerosis patients receiving interferon beta

Background: Multiple sclerosis (MS) patients permanently confronted with serious challenges from treatment regimen. Developing a new questionnaire in MS management, through evaluation of patients’ perspectives and knowledge regarding treatment will help to identify the sources of tension, and to bui...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abolfazli, Roya, Elyasi, Azam, Javadi, Mohammad Reza, Gholami, Kheirollah, Torkamandi, Hassan, Amir-Shahkarami, Mohammad, Etemadifar, Masoud, Nasr, Zahra
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Iranian Neurological Association 2014
Materias:	Original Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4240934/ https://www.ncbi.nlm.nih.gov/pubmed/25422736

Ejemplares similares

Quality of Life Assessment in Patients with Multiple Sclerosis Receiving Interferon Beta-1a: A Comparative Longitudinal Study of Avonex and Its Biosimilar CinnoVex
por: Abolfazli, R., et al.
Publicado: (2012)

Iranian Pharmacists’ Knowledge, Attitude and Practice Regarding Counterfeit Drugs
por: Shahverdi, Shieda, et al.
Publicado: (2012)

Knowledge, attitudes and practice of nurse regarding adverse drug reaction reporting
por: Hanafi, Somayeh, et al.
Publicado: (2012)

An educational intervention to improve nurses’ knowledge, attitude, and practice toward reporting of adverse drug reactions
por: Hanafi, Somayeh, et al.
Publicado: (2014)

The Evaluation of Albumin Utilization in a Teaching University Hospital in Iran
por: Jahangard-Rafsanjani, Zahra, et al.
Publicado: (2011)

Role of pharmacist counseling in pharmacotherapy quality improvement
por: Sanii, Yalda, et al.
Publicado: (2016)

Fatigue, depression, and physical impairment in multiple sclerosis
por: Azimian, Mojtaba, et al.
Publicado: (2014)

Patient preferences for Interferon-beta in Iran: A discrete choice experiment
por: Rahimi, Farimah, et al.
Publicado: (2018)

Thrombotic Microangiopathy in Interferon‐beta‐Treated Multiple Sclerosis Patient
por: Malekzadeh, Masoud Mohammad, et al.
Publicado: (2020)

Interferon beta-1b-induced thrombotic thrombocytopenic purpura-hemolytic uremic syndrome (TTP-HUS) in a patient treated for multiple sclerosis: A case report
por: Etemadifar, Masoud, et al.
Publicado: (2018)

Plasma Vitamin D Status and Its Correlation with Risk Factors of Thrombosis, P-selectin and hs-CRP Level in Patients with Venous Thromboembolism; the First Study of Iranian Population
por: Entezari-Maleki, Taher, et al.
Publicado: (2014)

Antituberculosis Drug-Induced Hepatotoxicity in IranianTuberculosis Patients: Role of Isoniazid Metabolic Polymorphism
por: Sistanizad, Mohammad, et al.
Publicado: (2011)

Tolerability and Safety Profile of a New Brand-Generic Product of Glatiramer Acetate in Iranian Patients with Relapsing-Remitting Multiple Sclerosis: An Observational Cohort Study()
por: Abolfazli, Roya, et al.
Publicado: (2018)

A Novel Splicesite Mutation in the EDAR Gene Causes Severe Autosomal Recessive Hypohydrotic (Anhidrotic) Ectodermal Dysplasia in an Iranian Family
por: Torkamandi, Shahram, et al.
Publicado: (2016)

Mycophenolate mofetil in combination with interferon beta-1a in the treatment of relapsing-remitting multiple sclerosis: A preliminary study
por: Etemadifar, Masoud, et al.
Publicado: (2011)

Pediatric hospital admission due to adverse drug reactions: Report from a tertiary center
por: Gholami, Kheirollah, et al.
Publicado: (2015)

Rapid exacerbation of multiple sclerosis following the initiation of interferon-β: report of nine cases
por: Etemadifar, Masoud, et al.
Publicado: (2011)

Parkinsonism associated with multiple sclerosis: A report of eight new cases and a review on the literature
por: Etemadifar, Masoud, et al.
Publicado: (2014)

The outbreak fingolimod cardiovascular side effects in relapsing-remitting multiple sclerosis patient: A longitudinal study in an Iranian population
por: Abdar, Morteza, et al.
Publicado: (2016)

Investigating the predictive of risk-taking attitudes and behaviors among Iranian drivers
por: Habibi, Ehsanollah, et al.
Publicado: (2014)

A community pharmacy-based cardiovascular risk screening service implemented in Iran
por: Jahangard-Rafsanjani, Zahra, et al.
Publicado: (2017)

DNMT3B-579G>T (rs1569686G>T) polymorphism and the risk of multiple sclerosis in a subset of Iranian population
por: Yazdanpanahi, Nasrin, et al.
Publicado: (2019)

Predictive performance of Vancomycin population pharmacokinetic models in Iranian patients underwent hematopoietic stem cell transplantation
por: Taghizadeh-Ghehi, Maryam, et al.
Publicado: (2015)

A comprehensive review of adherence to diabetes and cardiovascular medications in Iran; implications for practice and research
por: Sarayani, Amir, et al.
Publicado: (2013)

Willingness to Receive a COVID-19 Vaccine in an Iranian Population: Assessment of Attitudes, Perceived Benefits, and Barriers
por: Falahati, Mohsen, et al.
Publicado: (2022)

The Incidence of Amikacin Ototoxicity in Multidrug-ResistantTuberculosis Patients
por: Javadi, Mohammad Reza, et al.
Publicado: (2011)

The Effect of Curcumin on some of Traditional and Non-traditional Cardiovascular Risk Factors: A Pilot Randomized, Double-blind, Placebo-controlled Trial
por: Mirzabeigi, Parastoo, et al.
Publicado: (2015)

A homozygous missense mutation of WFS1 gene causes Wolfram's syndrome without hearing loss in an Iranian family (a report of clinical heterogeneity)
por: Torkamandi, Shahram, et al.
Publicado: (2020)

Antibodies to Interferon beta in Patients with Multiple Sclerosis Receiving CinnoVex, Rebif, and Betaferon
por: Zare, Nasrin, et al.
Publicado: (2013)

Self-Reported safety of the BBIBP-CorV (Sinopharm) COVID-19 vaccine among Iranian people with multiple sclerosis
por: Etemadifar, Masoud, et al.
Publicado: (2022)

Prescribing for geriatrics in Tehran; is it appropriate and rational?
por: Kargar, Mona, et al.
Publicado: (2019)

Safety and Discontinuation Rate of Dimethyl Fumarate (Zadiva(®)) in Patients with Multiple Sclerosis: An Observational Retrospective Study
por: Abolfazli, Roya, et al.
Publicado: (2023)

Serum leptin levels in Iranian patients with Parkinson's disease
por: Salari, Mehri, et al.
Publicado: (2018)

Association of CpG-SNP and 3'UTR-SNP of WFS1 with the Risk of Type 2 Diabetes Mellitus in an Iranian Population
por: Torkamandi, Shahram, et al.
Publicado: (2017)

Iranian consensus on use of vitamin D in patients with multiple sclerosis
por: Jahromi, Soodeh Razeghi, et al.
Publicado: (2016)

Comparison of Efficacy and Safety of Two Different Enoxaparin Products in Prevention of Venous Thromboembolism Following Major Obstetric-gynecological Surgeries: An Open-label Randomized Clinical Trial
por: Abdolvand, Manoochehr, et al.
Publicado: (2019)

Beta-interferons in multiple sclerosis
por: Aggarwal, Sourabh, et al.
Publicado: (2010)

Thrombotic microangiopathy associated with interferon-beta treatment in patients with multiple sclerosis
por: Baghbanian, Seyed Mohammad, et al.
Publicado: (2018)

Conversion from Radiologically Isolated Syndrome to Multiple Sclerosis
por: Etemadifar, Masoud, et al.
Publicado: (2014)

A two-year utilization of the pharmacist-operated drug information center in Iran
por: Entezari-Maleki, Taher, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_pssvtp42gba30rdt4gnrnnrn8e